why choose us

First received: August 14, 2023

Clinical Trial: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Adult Volunteers

Study Type: INTERVENTIONAL


Official Title: A First-in-Human Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Single Ascending Dose in Healthy Volunteers

Brief Summary: This is a randomized, double-blind, placebo-controlled dose escalation study to evaluate the safety, tolerability, PK, PD, and immunogenicity of IV administered DR-0201 in healthy volunteers.

Read more